Progress in Pharmaceutical Sciences 2012 Issue 5 kang gan ran yao wu nvc-422

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Progress in Pharmaceutical Sciences
1001-5094
2012 Issue 5

kang gan ran yao wu nvc-422

..............page:232-233

atx-101 de qi lin chuang shi yan huo yang xing jie guo

..............page:237-238

quan qiu xie tong ying dui ri yi fan lan de kang jun yao wu nai yao xing wen ti
fan ming

..............page:234-235

Factors Affecting Drug Release from Sustained Release Hydrophilic Matrices
GUI Bin;LIN Qiao-ping;XU Xiang-yang;ZHOU Jian-ping

..............page:216-223

duo fa xing ying hua zheng zhi liao yao alemtuzumab de qi lin chuang yan jiu you huo xin shu ju

..............page:237

fei dong mai gao ya zhi liao yao macitentan guan jian xing qi lin chuang shi yan huo de yang xing jie guo

..............page:240

hiv xiang guan xing zhi fang dai xie zhang ai zong he zheng zhi liao yao ti mo rui lin

..............page:231-232

han a li ke lun de jiang ya yao de shuo ming shu xin zeng jing gao he jin ji zheng

..............page:241

yong yu bing xing gan yan de yi zhong wu gan rao su lian yong zhi liao fang an qi lin chuang shi yan huo de yang xing jie guo

..............page:239-240

jak3 yi zhi ji tafacitinib yong yu zhi liao lei feng shi xing guan jie yan de shang shi shen qing zai ou zhou jin ru shen ping cheng xu

..............page:235-236

Development Mechanisms of Diabetic Nephropathy and the Possible Therapeutic Ways
GAO Jie;DAI De-zai;DING Xuan-sheng;DAI Yin

..............page:193-199

ren yuan hua kang cd20 dan ke long kang ti obinutuzumab

..............page:233-234

bretuximab vedotin chan pin shuo ming shu xin zeng hei kuang jing gao he jin ji zheng

..............page:240-241

gao san zuo gan you zuo xue zheng zhi liao yao epanovatm qi lin chuang shi yan huo de yang xing jie guo

..............page:239

luaa21004 you wang yong yu zhi liao zhong xing yi yu zhang ai

..............page:238-239

Application of Negishi Coupling Reaction in the Synthesis of Biphenyl Group in Sartans
WANG Xiao-dong;HUANG Su-ping;SHI Min;HAO Wei-qiang;CHEN Qiang

..............page:227-230

Strategies of the Biological Therapy for Malignant Lymphoma
LIU Bin;ZHANG Xiu-hua;PING Tao;CAO Rong-yue

..............page:207-215

hcv dan bai mei yi zhi ji bo sai po wei yu mou xie hiv dan bai mei yi zhi ji bu ke tong fu

..............page:240

xin xi dong tai

..............page:230

zhi duan fei da zheng zhi liao yao pasireotide chang xiao huan shi zhi ji liao xiao you yu ao qu zuo chang xiao huan shi zhi ji

..............page:236-237

latuda zai zhi liao shuang xiang i xing yi yu zheng de qi lin chuang shi yan zhong huo yang xing jie guo

..............page:238

bevacizumab cun zai yan zhong bu liang fan ying

..............page:241

The Influence of Gut Microbiota on Some Diseases and Drug Effect or Toxicity
WANG Xin-wen;A Ji-ye;CAO Bei;LIU Lin-sheng;ZHAO Chun-yan;CHEN Xiao-hu;WANG Guang-ji

..............page:199-207

Observation on Analgesic Effect and Adverse Reaction of Primacaine Adrenaline in the Dental Operation
MA Guo-qiang

..............page:224-227